Nisa Investment Advisors
NUVB icon

Nisa Investment Advisors’s Nuvation Bio NUVB Stock Holding History

Nisa Investment Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6K Buy
2,479
+1
+0% +$6 ﹤0.01% 2225
2025
Q4 		$22.2K Sell
2,478
-964
-28% -$5.97K ﹤0.01% 1904
2025
Q3 		$12.7K Hold
3,442
– – ﹤0.01% 2189
2025
Q2 		$6.71K Buy
3,442
+3,315
+2,610% +$6.91K ﹤0.01% 2393
2025
Q1 		$224 Sell
127
-703
-85% -$1.6K ﹤0.01% 2912
2024
Q4 		$2.21K Buy
830
+686
+476% +$1.77K ﹤0.01% 2454
2024
Q3 		$330 Sell
144
-265
-65% -$808 ﹤0.01% 2790
2024
Q2 		$1.19K Buy
409
+265
+184% +$809 ﹤0.01% 2477
2024
Q1 		$524 Buy
144
+17
+13% +$33 ﹤0.01% 2491
2023
Q4 		$192 Sell
127
-25,623
-100% -$33K ﹤0.01% 2563
2023
Q3 		$34.5K Sell
25,750
-240
-0.9% -$399 ﹤0.01% 1840
2023
Q2 		$46.8K Buy
25,990
+13,470
+108% +$22.9K ﹤0.01% 1769
2023
Q1 		$21K Buy
12,520
+12,280
+5,117% +$24.9K ﹤0.01% 1996
2022
Q4 		$0 Buy
+240
New +$486 ﹤0.01% 2666
2022
Q2 		– Sell
-2,700
Closed -$14K – 2469
2022
Q1 		$14K Buy
+2,700
New +$15.2K ﹤0.01% 2136

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nisa Investment Advisors's NUVB Position: Q1 2026 in Review

Nisa Investment Advisors increased its Nuvation Bio (NUVB) stake by 0.04% in Q1 2026, buying an estimated $6 and bringing the position to 2,479 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2225.

Nisa Investment Advisors first reported a position in NUVB in Q1 2022 and has held it in 15 quarters since. The position peaked at $46.8K in Q2 2023. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Nisa Investment Advisors held 2,479 shares of Nuvation Bio worth $10.6K as of Q1 2026.
  • Nisa Investment Advisors bought 1 Nuvation Bio share in Q1 2026, an estimated $6.
  • Nuvation Bio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2225 holding.
  • Nisa Investment Advisors first reported a position in Nuvation Bio in Q1 2022 and has held it in 15 quarters since.
  • Nisa Investment Advisors's Nuvation Bio position peaked at $46.8K in Q2 2023.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.